MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Kodu・Aktsiate loetelu・Novavax Inc

Novavax Inc

Avatud

SektorTervishoid

7.01 -0.71

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

6.81

Max

7.09

Põhinäitajad
By Trading Economics
Sissetulek	40M -81M
Müük	3.8M 88M
Aktsiakasum	-0.52
Kasumimarginaal	-91.755
Töötajad	952
EBITDA	52M -53M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+101.56% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	9. mai 2025

Turustatistika
By TradingEconomics
Turukapital	-299M 967M
Eelmine avamishind	7.72
Eelmine sulgemishind	7.01

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

5.6 / 6.467 Toetus ja vastupanu

Novavax Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

2. apr 2025, 17:06 UTC

Suurimad hinnamuutused turgudel

Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status

31. märts 2025, 14:19 UTC

Suurimad hinnamuutused turgudel

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

4. veebr 2025, 18:52 UTC

Suurimad hinnamuutused turgudel

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

11. nov 2024, 14:05 UTC

Suurimad hinnamuutused turgudel

Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold

16. okt 2024, 12:59 UTC

Suurimad hinnamuutused turgudel

Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines; Shares Drop

13. mai 2024, 18:14 UTC

Suurimad hinnamuutused turgudel

Novavax Shares Pop Another 50% Following Sanofi Deal

10. mai 2024, 10:59 UTC

Suurimad hinnamuutused turgudel

Novavax Shares Surge on $1.4 Billion Vaccine Licensing Deal with Sanofi

30. dets 2024, 23:02 UTC

Omandamised, ülevõtmised, äriostud

Novavax Completes Previously Announced $200M Sale of Czech Republic Manufacturing Site to Novo Nordisk

4. dets 2024, 07:09 UTC

Omandamised, ülevõtmised, äriostud

Novavax: Agreement to Close by Dec 30 >NVAX

4. dets 2024, 07:08 UTC

Omandamised, ülevõtmised, äriostud

Novavax: Sale Aligns With Plan to Become More Lean Organization, Drive Value From Pipeline Assets & Tech Platform >NVAX

4. dets 2024, 07:07 UTC

Omandamised, ülevõtmised, äriostud

Novavax: Deal to Also Reduce Annual Operating Costs by About $80M >NVAX

4. dets 2024, 07:06 UTC

Omandamised, ülevõtmised, äriostud

Novavax to Get $190M Cash Payment in 2024, Additional $10M in 2025 >NVAX

4. dets 2024, 07:06 UTC

Omandamised, ülevõtmised, äriostud

Novavax: Agreement Provides Company With Significant, Non-Dilutive Capital >NVAX

4. dets 2024, 07:04 UTC

Omandamised, ülevõtmised, äriostud

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200M

15. nov 2024, 13:34 UTC

Peamised uudised

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

15. nov 2024, 11:14 UTC

Market Talk

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

16. okt 2024, 15:22 UTC

Tulu

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, DJT, Novavax, J.B. Hunt, Cisco, and More -- Barrons.com

10. mai 2024, 20:11 UTC

Tulu

These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital, JFrog, SoundHound, and More -- Barrons.com

10. mai 2024, 14:49 UTC

Tulu

Kuumad aktsiad

Stocks to Watch Friday: TSMC, Novavax, Nvidia -- WSJ

10. mai 2024, 10:47 UTC

Omandamised, ülevõtmised, äriostud

Novavax Gets $1.4 Billion Deal With Sanofi. The Stock Jumps. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Novavax Inc Prognoos

Hinnasiht

By TipRanks

101.56% tõus

12 kuu keskmine prognoos

Keskmine 14.25 USD 101.56%

Kõrge 19 USD

Madal 9 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Novavax Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi Novavax Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

5.6 / 6.467Toetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bearish.

Bearish events outweigh bullish events.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.